- Cost effective, transparent kit pricing
- Free from antigen excess (found in other methods) reducing repeats
- Wide dynamic range requiring fewer dilutions/repeats than other methods
Utilising well characterised1*, highly specific, highly sensitive monoclonal detection antibodies, Seralite®– FLC ELISA provides a robust and easy to use option for serum free light chain (FLC) testing. Seralite®– FLC ELISA uses the same monoclonal antibodies as our established lateral flow method to provide accurate measurement of both kappa and lambda free light chains in the serum of patients with Multiple Myeloma and associated conditions.
Seralite®– FLC ELISA is a 2 plate, 96 well (12×8 well strip) kit that is scalable and is ideal for laboratories introducing FLC testing by either manual methods or using automated ELISA platforms. This scalability also enables high volume laboratories to integrate Seralite®– FLC ELISA smoothly into their workflow.
The sandwich ELISA format provides a wide dynamic range and together with the absence of antigen excess found in other FLC testing methods simplifies the laboratory workflow with reduced dilutions.
The measurement of FLC for the diagnosis and monitoring of multiple myeloma and related disorders is widely published (1,2,3,4)*. International guidelines recommend measurement of serum free light chains to aid in the diagnosis and monitoring of multiple myeloma5,6,7*.
Use of Seralite®-FLC ELISA can facilitate:
Confidence in Results
*Please see Resources page for a full list of references.
Seralite®-FLC ELISA Format
Reliable, Repeatable, Reproducible, Cost Effective Seralite®– FLC ELISA is a scalable high-throughput […]Read More
Need our help with your lateral flow assay growth strategy? https://t.co/Z4zDmKnw35 https://t.co/UjkKdqwhpU
26 May 2017
© Abingdon Health 2017